Profound Medical (PROF) Asset Utilization Ratio (2025 - 2026)
Profound Medical (PROF) recorded quarterly Asset Utilization Ratio of 0.25 in Q1 2026, down 7.25% quarter-over-quarter from 0.27 in Q4 2025, and up 44.72% on a YoY basis from 0.17 in Q1 2025.
Profound Medical (PROF) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Profound Medical's Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.25 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 44.72% year-over-year to 0.25; the TTM figure through Mar 2026 stood at 0.25 (up 44.72% YoY), while the FY2025 annual figure was 0.22, up 16.53% from the prior year.
- Asset Utilization Ratio was 0.25 for Q1 2026 at Profound Medical, down from 0.27 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.31 in Q3 2025 to a low of 0.17 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 0.39 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.47 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 0.57 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.65 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 0.74 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 0.56 |
| 10 | Profound Medical | 240.29 Mn | 190.00 Mn | 3.83 Mn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.31 |
| Jun 30, 2025 | 0.21 |
| Mar 31, 2025 | 0.17 |